fashion -WSS

fashion

author：entertainment 2025-10-01 18:03:49 - browse：3

research funding, medical devices — APStock

WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss a lawsuit challenging Medicare’s new drug price negotiation program from the drug industry lobbying organization PhRMA.

The move is an early but positive sign for the Biden administration in a legal fight that could stretch for years, as a host of major drugmakers, including Merck, Bristol Myers Squibb, and Johnson & Johnson, have also filed lawsuits over the constitutionality of Medicare’s new powers. The first round of drug negotiations is ongoing, and a judge heard oral arguments in a challenge brought by AstraZeneca just last month.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

The National Infusion Center Association and the Global Colon Cancer Association are also plaintiffs in PhRMA’s lawsuit. The judge dismissed the National Infusion Center Association from the case because it did not have subject matter jurisdiction to bring the lawsuit. And because NICA was the only party to the lawsuit that resides in Texas, the judge tossed out the case in its entirety.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Clinicians often fail to acknowledge the pain caused by long Covid

leisure time

WSS

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Achieving telehealth equity for people with hearing loss

Lawsuit challenges CMS nursing home minimum staffing rule

New research sheds light on how often breast cancer is overdiagnosed

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

The Bio Revolution is changing business and society

knowledge

fashion

Sign up for D.C. Diagnosis

entertainment

How to save PrEP access — and even expand it

Why some fertility treatments produce more boy babies

Hepatitis C has a cure — but many Americans still lack access to it

Why we need mandatory labeling of GMO products

Jerome Adams on the need for new antivirals for Covid

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

BioMarin wins approval for gene therapy to treat hemophilia A

Pharma’s losing bet in New Jersey

In age of alternative facts, a scholarly course on calling out crap

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

explore

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Guardant Health colon cancer test endorsed by FDA advisory panel

Louisiana bill approved classifying abortion pills as controlled substances

Medical students need to learn the potent medicine of empathy

Should insurance cover cosmetic surgery?

Ozempic cut risk of death in diabetes patients with chronic kidney disease

knowledge

leisure time

entertainment

explore